Advances in Gastrointestinal (GI) Cancers: A Virtual International Conference

March 28, 2021

The care of GI cancers is advancing at a rapid pace. ‘Advances in Gastrointestinal (GI) Cancers: A Virtual International Conference’ is a CME-accredited virtual conference that brings together the leading experts from around the world to discuss recent advances in the field of GI oncology with a focus on biomarker-driven therapies, immuno-oncology, and clinical applications of the recent advances across various GI tumor types. This meeting will provide an opportunity to hear from the leading national and international experts on how recently published data would change practice, some of which will have immediate clinical applications. Furthermore, each session will have multiple segments on novel emerging treatment paradigms likely to transform the care of GI cancers in the near future.

This virtual conference is intended to propagate new information to augment the knowledge and clinical competence of the cancer care providers in the following areas:

  • Emerging role of immunotherapy in the field of GI cancers
  • Evolving role of circulating tumor DNA (ctDNA) in the management of colorectal cancer
  • Novel emerging therapies for pancreatic cancer
  • Novel treatment options for rectal cancer, including non-operative protocol 
  • Trends, challenges, and controversies in the management of GI cancers

REGISTRATION FEES: 

Registration is free for healthcare providers who are NOT employees of ACCME defined ineligible companies.

If you are a healthcare provider involved in patient care and are not an employee of an ineligible company, please proceed to registration and select "non-industry learner" and your fee will reset to $0.00.

An ineligible company is any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients with the exception of hospitals and facilities that provide direct care to patients. If you are an employee of an ineligible company, please select "industry representative" and pay the industry registration fee when registering for this course. 

If you are an employee of the industry and select yourself as “non-industry learner” to avoid paying the registration fee, an additional amount equivalent to the registration fee will be assessed as a penalty. No employee of your company will be able to attend our educational meetings or exhibit at our conferences until the registration fee and the penalty is paid in full

Target Audience

  • Oncologists
  • Hematologists
  • Residents/Fellows
  • NPs/PAs
  • Pharmacists
  • Nurses

Learning Objectives

Upon successful completion of this educational activity, participants will be able to:

  • Discuss the role of immunotherapy in various GI cancers
  • Review the role of novel biomarkers directing the therapy of GI cancers.
  • Compare and contrast the safety and efficacy of competing therapeutic strategies  influencing the management of GI cancers
  • Describe the application of emerging data into the treatment strategies of GI cancers
  • Identify the areas where precision medicine driven therapy personalizations play an essential role.
Course summary
Available credit: 
  • 4.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 4.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 4.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 4.25 Contact Hours.
Course opens: 
02/08/2021
Course expires: 
04/28/2021
Event starts: 
03/28/2021 - 7:30am PDT
Event ends: 
03/28/2021 - 1:15pm PDT
Cost:
$1.00
Add to calendar: 
All times are listed in Pacific Standard Time (PST)
March 28, 2021 

7:15 AM PST: Zoom Link Opens

7:15 AM to 7:30 AM PST: Networking 

7:30 AM to 7:55 AM PST: Exhibit/Attendance/Networking

7:55 AM to 8:00 AM PST: Introduction/Welcome

Session 1: Gastroesophageal cancer

8:00 AM to 8:25 AM PST: Gastroesophageal cancer: Recent advances - Dr. Daniel Catenacci (25 minutes)

8:25 AM to 8:40 AM PST: Straight talk: Should induction chemotherapy be used before concurrent chemoradiation in the treatment of locally advanced gastroesophageal junction carcinoma? - Dr. Joseph Chao (15 minutes)

Session 2: Hepatobiliary Cancer

8:40 AM to 9:05 AM PST: Hepatobiliary cancer: Recent advances - Dr. Ghassan Abou-Alfa (25 minutes)

9:05 AM to 9:20 AM PST: Straight talk: Should all patients with advanced biliary tract cancer get genomic study at the time of diagnosis? - Dr. Bhawna Sirohi (15 minutes)

9:20 AM to 9:35 AM PST: Straight talk: Role of neoadjuvant chemotherapy in resectable biliary tract cancer - Dr. Rachna Shroff (15 minutes)

9:35 AM to 10:00 AM PST: Questions and answer

10:00 AM to 10:30 AM PST: Break/Exhibits

Session 3: Pancreatic Cancer & Neuroendocrine Tumor (NET)

10:30 AM to 10:55 AM PST: Pancreatic cancer: Recent advances - Dr. Eileen O'Reilly (25 minutes)

10:55 AM to 11:10 AM PST: Straight talk: Immunotherapy in pancreatic cancer- ready for prime time? - Dr. Andrew Coveler (15 minutes)

11:10 AM to 11:25 AM PST: Straight talk: Which patients with NET should get PRRT and when? - Dr. Aman Chauhan (15 minutes)

11:25 AM to 11:35 AM PST: Questions and answer

11:35 AM to 12:00 PM PST: Break/Exhibit

Session 4: Colorectal cancer

12:00 PM to 12:25 PM PST: Colorectal cancer: Recent advances - Dr. Axel Grothey (25 minutes)

12:25 PM to 12:40 PM PST: Straight talk: Watch and Wait for Rectal Cancer: Why, Who, and How? - Dr. Sakti Chakrabarti (15 minutes)

12:40 PM to 12:55 PM PST: Straight talk: How I use ctDNA in patients with early-stage colon cancer - Dr. Aparna Parikh (15 minutes)

12:55 PM to 01:10 PM PST: Questions and answer

01:10 PM to 01:15 PM PST: Concluding remarks

 

This meeting is held virtually on Zoom. Register for the activity to participate.

Once you sign up, you will receive a confirmation email. However, you will not receive a zoom link via email to join this meeting.

You will need to log into the activity page to access the zoom link on the day of the meeting. The link will be accessible about 30 minutes before the meeting starts.

 

Aparna R. Parikh, MD

Assistant Professor of Medicine

Harvard Medical School

Learn More

Rachna T. Shroff, MD, MS

Associate Professor of Medicine 

The University of Arizona

Learn More

Eileen O'Reilly, MD

Professor of Medicine

Memorial Sloan Kettering Cancer Center & Cornell University

Learn More

Sakti Chakrabarti, MD

Associate Professor of Medicine

Medical College of Wisconsin

Learn More

Ghassan Abou-Alfa, MD

Professor of Medicine

Memorial Sloan Kettering Cancer Center & Cornell University

Learn More

Joseph Chao, MD

Assistant Clinical Professor

City of Hope

Learn More

Andrew Coveler, MD

Associate Professor of Medicine

University of Washington

Learn More

Axel Grothey, MD

Medical Oncologist/Hematologist

West Cancer Center

Learn More

Daniel Catenacci, MD

Associate Professor of Medicine

University of Chicago

Learn More

Aman Chauhan, MD

Assistant Professor of Medicine

University of Kentucky

Learn More

Bhawna Sirohi, MD

Medical Oncologist

Apollo Proton Cancer Centre, Chennai, India 

Learn More

  

 

 

The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians.

The Binaytara Foundation designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the criteria for up to 4.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.

Nursing Contact Hours 

Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 4.25 Contact Hours.

ABSM Maintenance of Certificate Recognition Statement: 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

DISCLOSURE OF CONFLICT OF INTEREST:

No individuals in control fo this activity's contents have any relevant financial relationship with an ineligible entity with the exception of the following faculties:

● Dr. Arpana Parikh: Ad Board/Research Funding to Institution -Pfizer, Eli Lilly, Natera, Checkmate, CVS, PMV Pharma, Array, BMS, Guardant, and Novartis.

● Dr. Eileen O’Reilly: Consultant- Celgene-BMS (Spouse), Sobi, Molecular Templates, Boehringer Igelheim, Ipsen, Polaris, Merck, Bayer (Spouse, Eisai (Spouse). Research support/Grant - Genentech-Roche, Celgene-BMS, BioNTech, AstraZenica, Arcus. Other (DSMB) - CytomX Therapeutics, Rafael Therapeutics.

● Dr. Ghassan Abou-Alfa: Research Support/Grant - ActaBiologica, Agios, AstraZeneca, Bayer, Beigene, Berry Genomics, BMS, Casi, Celgene, Exelixis, Genentech/Roche, Halozyme, Incyte, Mabvax, Puma, QED, Sillajen, Yiviva. Consultant - Agios, Astra Zeneca, Autem, Bayer, Beigene, Berry Genomics, Celgene, CytomX, Debio, Eisai, Eli Lilly, Exelixis, Flatiron, Genentech/Roche, Gilead, Helio, Incyte, Ipsen, Loxo, Merck, MINA, Polaris, QED, Redhill, Silenseed, Sillajen, Sobi, Therabionics, Twoxar, Vector, Yiviva.

● Dr. Daniel Catenacci: Consultant - Genentech/Roche, Amgen, and honoraria from Genentech/Roche, Amgen, Eli Lilly, Five Prime, Merck, BMS, Taiho, Astellas, Gritstone, Pieris, Daiichi Sankyo, Zymeworks, QED, Foundation Medicine, Tempus, Guardant Health, Archer & Natera.

● Dr. Aman Chauhan - Research Support/Grant - BMS, Clovis, TerSera, Lexicon, Nanopharmeceuticals, EMD Serono. Consultant - Novartis, Ipsen, TerSera, Lexicon.

● Dr. Joseph Chao - Grant/Research Support - Merck. Consultant - Merck, Macrogenics, Foundation Medicine.

● Dr. Andrew Coveler - Grant/Research Support - Medimmune, Seattle Genetics, Amgen Nucana, Abgenomics, Halozyme, Novocure.

● Dr. Axel Grothey - Grant/Research Support - Genentech/Roche, Bayer, Array/Pfizer, Boston Biomedicals, Daiichi. Consultant - Genentech/Roche, Bayer, Array/Pfizer, Daichi Sankyo.

● Dr. Sakti Chakrabarti - Consultant - HalioDx, QED Therapeutics, DAVA Oncology, BioMedical Insights, Inc. Grant/Research Support - MERCK, Taiho Pharmaceutical, Natera, Roche

Available Credit

  • 4.25 AMA PRA Category 1 Credit™
    The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 4.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 4.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
  • 0.00 Attendance
  • 4.25 Nursing Contact Hours
    Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 4.25 Contact Hours.

Please visit our sponsors and exhibitors in the main exhibit breakout room during the exhibit presentations.

Please note that exhibit presentations are promotional materials separate from the accredited activities. These presentations are held in the exhibit breakout room during designated exhibit hours.

We encourage you to visit the main exhibit breakout room and each company's breakout rooms during exhibit and break hours. 

The following Exhibitors will be making exhibit presentations during the exhibit hours:

CompanyRep contactLink to Exhibit Materials and Prescribing information
Bristol Myers SquibbMariana Boussard

http://packageinserts.bms.com/pi/pi_opdivo.pdf

http://packageinserts.bms.com/pi/pi_yervoy.pdf

GenentechHeather Freeborne

https://www.tecentriq.com/ 

HalioDxHarpreet Bindrahttps://binaytarafoundation.box.com/s/qfif2lq0x11zqp8e1b8jb43q4few72wu
EisaiAsh Samjihttps://eisai.oncportfolio.com/#lenvima
PfizerDarci Aederhttps://www.pfizeroncologycongressresources.com/B

 

Price

Cost:
$1.00
Please login or register to take this course.

REGISTRATION FEES: 

Registration is free for healthcare providers who are NOT employees of ACCME defined ineligible companies. Please proceed to registration and select "non-industry learner" if you are a healthcare provider involved in patient care and are not an employee of an ineligible company. Your fee will reset to $0.00.

An ineligible company is any entity producing, marketing, re-selling, or distributing healthcare goods or services consumed by, or used on, patients with the exception of hospitals and facilities that provide direct care to patients. If you are an employee of an ineligible company, please select "industry representative" and pay the industry registration fee when registering for this course.

All employees of an ineligible company (formerly: commercial interest) must register as "Industry" and pay a registration fee even if they are licensed as healthcare providers. If you are an employee of the industry and select yourself as “healthcare provider NOT employed by the industry” to avoid paying the registration fee, an additional amount equivalent to the registration fee will be assessed as a penalty, and no employee of your company will be able to attend our educational meetings or exhibit at our conferences until the registration fee and the penalty is paid in full.

 

Cancellation Policy

You may cancel your enrollment at any time. No credits will be offered if you do not complete all required steps of this activity which include registration, participation in the live activity via Zoom, and completion of pre & post tests as well as course evaluations.

 

Refund Policy 

This activity is free for all healthcare providers who are not employees of an ineligible entity.

No refunds will be issued if you are unable to attend the live meeting after enrollment.

Required Hardware/software

This activitywill be held virtually on Zoom. You will need access to internet and a hardware such as a laptop or desktop computer or a mobile device with Zoom application installed.

For best audio-visual experience, please update your Zoom application before joining the meeting.